162 related articles for article (PubMed ID: 20371488)
1. Adipose tissue macrophages: a piece of the PAI of metabolic syndrome.
Lumeng CN
Sci Transl Med; 2010 Feb; 2(20):20ps7. PubMed ID: 20371488
[TBL] [Abstract][Full Text] [Related]
2. Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages.
Kishore P; Li W; Tonelli J; Lee DE; Koppaka S; Zhang K; Lin Y; Kehlenbrink S; Scherer PE; Hawkins M
Sci Transl Med; 2010 Feb; 2(20):20ra15. PubMed ID: 20371491
[TBL] [Abstract][Full Text] [Related]
3. Macrophages, immunity, and metabolic disease.
McNelis JC; Olefsky JM
Immunity; 2014 Jul; 41(1):36-48. PubMed ID: 25035952
[TBL] [Abstract][Full Text] [Related]
4. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity.
Heilbronn LK; Campbell LV
Curr Pharm Des; 2008; 14(12):1225-30. PubMed ID: 18473870
[TBL] [Abstract][Full Text] [Related]
5. Adipose tissue as an immunological organ.
Grant RW; Dixit VD
Obesity (Silver Spring); 2015 Mar; 23(3):512-8. PubMed ID: 25612251
[TBL] [Abstract][Full Text] [Related]
6. CD40L induces inflammation and adipogenesis in adipose cells--a potential link between metabolic and cardiovascular disease.
Missiou A; Wolf D; Platzer I; Ernst S; Walter C; Rudolf P; Zirlik K; Köstlin N; Willecke FK; Münkel C; Schönbeck U; Libby P; Bode C; Varo N; Zirlik A
Thromb Haemost; 2010 Apr; 103(4):788-96. PubMed ID: 20174757
[TBL] [Abstract][Full Text] [Related]
7. Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes.
Trost S; Pratley R; Sobel B
Curr Diab Rep; 2006 Feb; 6(1):47-54. PubMed ID: 16522281
[TBL] [Abstract][Full Text] [Related]
8. Imbalance between protective (adiponectin) and prothrombotic (Plasminogen Activator Inhibitor-1) adipokines in metabolic syndrome.
Ahirwar AK; Jain A; Goswami B; Bhatnagar MK; Bhatacharjee J
Diabetes Metab Syndr; 2014; 8(3):152-5. PubMed ID: 25042166
[TBL] [Abstract][Full Text] [Related]
9. Adipose tissue immune cells in obesity, type 2 diabetes mellitus and cardiovascular diseases.
Cinkajzlová A; Mráz M; Haluzík M
J Endocrinol; 2021 Nov; 252(1):R1-R22. PubMed ID: 34592714
[TBL] [Abstract][Full Text] [Related]
10. Inflammation, obesity, and thrombosis.
Samad F; Ruf W
Blood; 2013 Nov; 122(20):3415-22. PubMed ID: 24092932
[TBL] [Abstract][Full Text] [Related]
11. Re: "Plasminogen Activator Inhibitor-1 and Pericardial Fat in Individuals with Type 2 Diabetes Mellitus" by Bayomi et al. (Metab Syndr Relat Disord 2017;15:269-275).
Avogaro A
Metab Syndr Relat Disord; 2017 Aug; 15(6):266-268. PubMed ID: 28605281
[TBL] [Abstract][Full Text] [Related]
12. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.
Skurk T; Hauner H
Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1357-64. PubMed ID: 15356668
[TBL] [Abstract][Full Text] [Related]
13. Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes.
Fan R; Toubal A; Goñi S; Drareni K; Huang Z; Alzaid F; Ballaire R; Ancel P; Liang N; Damdimopoulos A; Hainault I; Soprani A; Aron-Wisnewsky J; Foufelle F; Lawrence T; Gautier JF; Venteclef N; Treuter E
Nat Med; 2016 Jul; 22(7):780-91. PubMed ID: 27270589
[TBL] [Abstract][Full Text] [Related]
14. Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice.
Cole BK; Keller SR; Wu R; Carter JD; Nadler JL; Nunemaker CS
Hypertension; 2010 Mar; 55(3):715-21. PubMed ID: 20100990
[TBL] [Abstract][Full Text] [Related]
15. Self-Nucleic Acid Sensing: A Novel Crucial Pathway Involved in Obesity-Mediated Metaflammation and Metabolic Syndrome.
Ferriere A; Santa P; Garreau A; Bandopadhyay P; Blanco P; Ganguly D; Sisirak V
Front Immunol; 2020; 11():624256. PubMed ID: 33574823
[TBL] [Abstract][Full Text] [Related]
16. Lymphocytes and macrophages in adipose tissue in obesity: markers or makers of subclinical inflammation?
Cinkajzlová A; Mráz M; Haluzík M
Protoplasma; 2017 May; 254(3):1219-1232. PubMed ID: 28150048
[TBL] [Abstract][Full Text] [Related]
17. Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome.
Khoukaz HB; Ji Y; Braet DJ; Vadali M; Abdelhamid AA; Emal CD; Lawrence DA; Fay WP
Arterioscler Thromb Vasc Biol; 2020 Jun; 40(6):1479-1490. PubMed ID: 32268785
[TBL] [Abstract][Full Text] [Related]
18. Properties and functions of adipose tissue macrophages in obesity.
Russo L; Lumeng CN
Immunology; 2018 Dec; 155(4):407-417. PubMed ID: 30229891
[TBL] [Abstract][Full Text] [Related]
19. The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levels.
Barnard SA; Pieters M; De Lange Z
Blood Rev; 2016 Nov; 30(6):421-429. PubMed ID: 27233154
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
Rega G; Kaun C; Weiss TW; Demyanets S; Zorn G; Kastl SP; Steiner S; Seidinger D; Kopp CW; Frey M; Roehle R; Maurer G; Huber K; Wojta J
Circulation; 2005 Apr; 111(15):1938-45. PubMed ID: 15837947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
